# Venous Thromboembolism Prevention in Outpatients With Glioma

> **NCT05683808** · PHASE2 · RECRUITING · sponsor: **University of Vermont Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma
- Astrocytoma
- Venous Thromboembolism

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT05683808
- **Lead sponsor:** University of Vermont Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-16
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05683808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05683808, "Venous Thromboembolism Prevention in Outpatients With Glioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05683808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*